Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-28T00:24:12.606Z Has data issue: false hasContentIssue false
  • English
  • Français

Resistance of Pseudomonas aeruginosa to Imipenem

Published online by Cambridge University Press:  21 June 2016

Harold C. Neu
Harold C. Neu*
Affiliation:
Division of Infectious Diseases/Epidemiology, Department of Medical, College of Physicians & Surgeons, Columbia University, New York, New York
*
FACP Division of infectious Diseases/Epidemiology, Department of Medicine, College of Physicians & Surgeons, Columbia University, 630 West 168 St., New York, NY 10032
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 1 , January 1992 , pp. 7 - 9
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

References

1. Gaynes, RP: Culver, DH, National Nosocomial Infections Surveillance System. Resistance to impenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol. 1992;13:10–14.10.2307/30146962CrossRefGoogle Scholar
2. Acar, JF Therapy for lower respiratory tract infections with imipenem/cilastatin: a review of worldwide experience. Rev Infect Dis. 1985;7(suppl 3):513–517.CrossRefGoogle ScholarPubMed
3. Kahan, JS, Kahan, FM, Goeglman, et al. Thienamcyin, a new b-lactam antibiotic. I. Discovery, taxonony, isolation, and physical properties. J Antibiot (Tokyo). 1979;32:1–12.CrossRefGoogle Scholar
4. Birnbaum, J, Kahan, FM, Kropp, H, MacDonald, JS. Carbapenems, a new class of b-lactam antibiotics. Am J Med. 1985;72(suppl 6A):3–21.CrossRefGoogle Scholar
5. Trias, J, Nikaido, H. Outer membrane protein D2 catalyzed diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemothel: 1990;34:52–57.CrossRefGoogle Scholar
6. Satake, S, Yoshihara, E, Nakae, T. Diffusion of b-lactam antibiotics through liposome membranes reconstituted from purified porins of the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother: 1990;34:685–690.CrossRefGoogle Scholar
7. Salata, RA, Gebhart, RL, Palmer, DL, et al. Pneumonia treated with imipenem/cilastatin. JAMA. 1985;78(suppl 6A): 96–102.Google ScholarPubMed
8. Quinn, JP, Dudek, EJ, Di Vencenzo, CA, Lucks, DA, Lerner, SA. Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. J Infect Dis. 1986;154:289–294.10.1093/infdis/154.2.289CrossRefGoogle ScholarPubMed
9. Buscher, KH, Cullmann, W, Dick, W, Opferkuch, W. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob Agents Chemother 1987;31:703–708.CrossRefGoogle ScholarPubMed
10. Trias, J, DuFresne, J, Levesque, RC, Nikaido, H. Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosa . Antimicrob Agents Chemother: 1989;33:1201–1206.CrossRefGoogle ScholarPubMed
11. Goto, M, Goto, S, Shimada, K. Frequency of isolation of Pseudomonas aeruginosa in 19 domestic hospitals and their drug susceptibility. Proceedings of the Annual Meeting Japanese Society Chemotherapy. Tokyo, Japan 1989. #232.Google Scholar
12. Satake, S, Yoneyama, H, Nakae, T. Role of Omp D2 and chromosomal b-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa . J Antimicrob Chemother: 1991;28:199–207.CrossRefGoogle Scholar
13. Kahan, FM, Drusano, GL, ISS Study Group. Resistance of gram-negative organisms isolated from ICU patients in four cities to b-lactam antibiotics. Presented at the Third Decennial Conference on Nosocomial Infections. July 31-August 2, 1990. Atlanta, Ga. #66.Google Scholar
14. Parry, ME Pazer, KB, Yokna, ME. Quinolone resistance: susceptibility data from a 300-bed community hospital. Am J Med. 1989;87(suppl 5A):12–16.CrossRefGoogle ScholarPubMed
15. Sanders, CC. Editorial: new b-lactams: new problems for the internist. Ann Intern Med. 1991;115:650–651.CrossRefGoogle Scholar
16. Lee, EH, Nicolas, MH, Kitzis, MD, Pialoux, G, Collatz, E, Gutmann, L. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob Agents Chemother: 1991;35:1093–1098.CrossRefGoogle Scholar
17. Raimondi, A, Traverso, A, Nikaido, H. Imipenem- and meropenem- resistant Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob Agents Chemother: 1991;35:1174–1180.CrossRefGoogle ScholarPubMed